Chang Liu - 25 Aug 2025 Form 3 Insider Report for Curanex Pharmaceuticals Inc

Role
10%+ Owner
Signature
/s/ Chang Liu
Issuer symbol
CURX on Nasdaq
Transactions as of
25 Aug 2025
Net transactions value
$0
Form type
3
Filing time
02 Sep 2025, 20:30:11 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Liu Chang 10%+ Owner C/O CURANEX PHARMACEUTICALS INC, 2 JERICHO PLAZA SUITE 101 B, JERICHO /s/ Chang Liu 02 Sep 2025 0002084036

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CURX Common Stock 4,870,020 25 Aug 2025 Direct
holding CURX Common Stock 2,340,000 25 Aug 2025 See footnote F1
holding CURX Common Stock 772,200 25 Aug 2025 See footnote F2
holding CURX Series A Preferred Stock 310,000 25 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock are held directly by Korovyev Hippo LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Korovyev Hippo LLC.
F2 These shares of common stock are held directly by Liu and Company LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Liu and Company LLC.